Skip to main content
SpringerLink
Log in
Book cover

Recent Concepts in Sarcoma Treatment pp 201–209Cite as

Treatment of Gynecologic Sarcomas

  • Chapter

  • 67 Accesses

Part of the book series: Developments in Oncology ((DION,volume 55))

Abstract

The primary treatment of female pelvic sarcomas is surgical; the details of surgery are discussed elsewhere. The focus of this report will be on the chemotherapy of gyn sarcomas, and particularly on uterine sarcomas, in regard to both early stage high-risk disease and advanced disease. Some brief comments about pathology, etiology, staging and other modes of treatment are also included for comparison and contrast with the general group of soft tissue sarcomas.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ober W: Uterine sarcomas: Histogenesis and taxonomy. Ann NY Acad Sci 75: 568–585, 1959.

    Article  PubMed  CAS  Google Scholar 

  2. Christopherson W, Williamson E, Gray L: Leiomyosarcoma of the uterus. Cancer 115 (29): 1512–1517, 1972.

    Article  Google Scholar 

  3. Banner A, Carrington C, Emory W, Kittle F, Leonard G, Ringus J, Taylor P, Addington W: Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma. N Engl J Med 305: 204–209, 1981.

    Article  PubMed  CAS  Google Scholar 

  4. Yoonessi M, Hart WR: Endometrial stromal sarcomas. Cancer 40: 898–906, 1977.

    Article  PubMed  CAS  Google Scholar 

  5. Soong SJ: Personal communication, 1987.

    Google Scholar 

  6. Salazar O, Bonfiglio T, Patten S, Keller B, Fieldstein M, Dunne M, Rudolph J: Uterine sarcomas, natural history, treatment and prognosis. Cancer 42: 1152–1160, 1978.

    Article  PubMed  CAS  Google Scholar 

  7. Badib A, Vongtama V, Kurohara S, Webster J: Radiotherapy in the treatment of sarcomas of the corpus uteri. Cancer 24: 724–729, 1969.

    Article  PubMed  CAS  Google Scholar 

  8. Vongtama V, Karlen J, Piver S, Tsukada Y, Moore R: Treatment results and prognostic factors in stage I and II sarcomas of the corpus uteri. Am J Radiol 126: 139–147, 1976.

    CAS  Google Scholar 

  9. Vardi J, Tovell H: Leiomyosarcoma of the uterus: Clinical pathologic study. Obstet Gynecol 56: 428–434, 1980.

    PubMed  CAS  Google Scholar 

  10. Meredith RF, Eisert DR, Kaka Z, Hodgson SE, Johnston GA, Boutselis JG: An excess of uterine sarcomas after pelvic irradiation. Cancer 58: 2003–2007, 1986.

    Article  PubMed  CAS  Google Scholar 

  11. Norris H, Taylor H: Post-irradiation sarcomas of the uterus. Obstet Gynecol 26: 689–694, 1965.

    PubMed  CAS  Google Scholar 

  12. Silverberg S: Leiomyosarcoma of the uterus. A clinical pathologic study. Obstet Gynecol 38: 613–627, 1971.

    Article  PubMed  CAS  Google Scholar 

  13. Messerschmidt G, Hoover R, Young R: Gynecologic cancer treatment: Risk factors for therapeutically induced neoplasia. Cancer 48: 442–450, 1981.

    Article  PubMed  CAS  Google Scholar 

  14. DiSaia P, Castro J, Rutledge F: Mixed mesodermal sarcoma of the uterus. A.J.R. 117: 632–636, 1973.

    CAS  Google Scholar 

  15. Major F, Silverberg S, Morrow P, Blessing J: A preliminary analysis of prognostic factors in uterine sarcoma. A Gynecologic Oncology Group Study. Proceedings f the Society of Gynecologic Oncologists (abstr.), 1987.

    Google Scholar 

  16. Omura GA, Blessing JA, Major F, Lifshitz S, Ehrlich CE, Mangan C, Beecham J, Park R, Silverberg S: A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: A Gynecologic Oncology Group Study. J Clin Oncol 3: 1240–1245, 1985.

    PubMed  CAS  Google Scholar 

  17. Salazar O, Bonfiglio T, Patten S, Keller B, Fieldstein M, Dunne M, Rudolph J: Uterine sarcomas, analysis of failures with special emphasis on the use of adjuvant radiation therapy. Cancer 42: 1161–1170, 1978.

    Article  PubMed  CAS  Google Scholar 

  18. Gilbert HA, Kagan AR, Lagasse L, Jacobs MR, Tawa K: The value of radiation therapy in uterine sarcoma. Obstet Gynecol 45: 84–88, 1975.

    PubMed  CAS  Google Scholar 

  19. Hornback NB, Omura G, Major FJ: Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma. Intl J Radiation Oncol Biol Phys 12: 2127–2130, 1986.

    Article  CAS  Google Scholar 

  20. Piver MS, Barlow JJ, Lele SB, Yazigi R: Adriamycin in localized and metastatic uterine sarcomas. J Surg Oncol 12: 263–265, 1979.

    Article  PubMed  CAS  Google Scholar 

  21. Yazigi R, Piver MS, Barlow JJ: Stage III uterine sarcoma: Case report and literature review. Gynecol Oncol 8: 92–96, 1979.

    Article  PubMed  CAS  Google Scholar 

  22. Lehrner LM, Mile PH, Enck RE: Complete remission of widely metastatic endometrial stromal sarcoma following combination chemotherapy. Cancer 43: 1189–1194, 1979.

    Article  PubMed  CAS  Google Scholar 

  23. Piver MS, DeEulis TG, Lele SB, Barlow JJ: Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract. Gynecol Oncol 14: 319–323, 1982.

    Article  PubMed  CAS  Google Scholar 

  24. Azizi F, Bitran J, Javehari G, Herbst A: Remission of uterine leiomyosarcomas treated with vincristine, adriamycin, and dimethyl-triazeno-imidazole carboximide. Am J Obstet Gynecol 133: 379–381, 1979.

    PubMed  CAS  Google Scholar 

  25. Omura GA, Shingleton HM, Creasman WT, Blessing JA, Boronow RC: Chemotherapy of gynecologic cancer with nitrosoureas: A randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva. Cancer Treat Rep 62: 833–835, 1978.

    PubMed  CAS  Google Scholar 

  26. Malkasian GD, Mussey E, Decker DG, Johnson CE: Chemotherapy of gynecologic sarcomas. Cancer Chemother Rep 51: 507–516, 1967.

    Google Scholar 

  27. Omura GA, Major FJ, Blessing JA, Sedlacek TV, Thigpen JT, Creasman WT, Zaino RJ: A randomized study of adriamycin with and without dimethyl triazeno imidazole carboxamide in advanced uterine sarcomas. Cancer 52: 626–632, 1983.

    Article  PubMed  CAS  Google Scholar 

  28. Muss HB, Bundy B, DiSaia P, Creasman W, Yordan P: Treatment of recurrent or advanced uterine sarcoma: A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide: A Phase III trial of the Gynecologic Oncology Group. Cancer 55: 1648–1653, 1985.

    Article  PubMed  CAS  Google Scholar 

  29. Thigpen JT, Blessing JA, Homesley HD, Hacker N, Curry SL: Phase II trial of piperazinedione in patients with advanced or recurrent uterine sarcoma: A Gynecologic Oncology Group Study. Am J Clin Oncol (CCT) 8: 350–352, 1985.

    Article  CAS  Google Scholar 

  30. Slayton RE, Blessing JA, DiSaia PJ, Christopherson WA: Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: A Gynecologic Oncology Group Study. Cancer Treat Rep 71: 661–662, 1987.

    PubMed  CAS  Google Scholar 

  31. Gershenson DM, Kavanagh JJ, Copeland LJ, Edward CL, Freedman RS, Wharton JT: High-dose doxorubicin infusion therapy for disseminated mixed mesodermal sarcoma of the uterus. Cancer 59: 1264–1267, 1987.

    Article  PubMed  CAS  Google Scholar 

  32. Thigpen JT, Blessing JA, Wilbanks GD: Cisplatin as second-line chemotherapy in the treatment of advanced or recurrent leiomyosarcoma of the uterus. Am J Clin Oncol (CCT) 9 (1): 18–20, 1986.

    Article  CAS  Google Scholar 

  33. Thigpen JT: Personal communication, 1987.

    Google Scholar 

  34. Gershenson DM, Kavanagh JJ, Copeland LJ, Edwards CL, Stringer CA, Wharton JT: Cisplatin therapy for disseminated mixed mesodermal sarcoma of the uterus. J Clin Oncol 5: 618–621, 1987.

    PubMed  CAS  Google Scholar 

  35. Thigpen JT, Blessing JA, Orr Jr. JW, DiSaia PJ: Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: A Gynecologic Oncology Group Study. Cancer Treat Rep 70: 271–274, 1986.

    PubMed  CAS  Google Scholar 

  36. Sutton G: Personal communication, 1987.

    Google Scholar 

  37. Buchsbaum HJ, Lifshitz S, Blythe JG: Prophylactic chemotherapy in stages I and II uterine sarcoma. Gynecol Oncol 8: 346–348, 1979.

    Article  PubMed  CAS  Google Scholar 

  38. Van Nagel Jr. JR, Hanson MB, Donaldson ES, Gallion HH: Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in stage I uterine sarcomas. Cancer 57: 1451–1454, 1986.

    Article  Google Scholar 

  39. Hannigan EV, Freedman RS, Rutledge FN: Adjuvant chemotherapy in early uterine sarcoma. Gynecol Oncol 15: 56–64, 1983.

    Article  PubMed  CAS  Google Scholar 

  40. Omura GA, Blessing JA: unpublished observations, 1987.

    Google Scholar 

  41. Rotmensch J, Rosenshein N, Woodruff J: Cervical sarcoma: A review. OB Gyn Survey 38: 456–460, 1983.

    Article  CAS  Google Scholar 

  42. Jawalekar KS, Zacharopoulou M, McCaffrey RM: Leiomyosarcoma of the cervix uteri. Southern Med J 74: 510–511, 1981.

    Article  PubMed  CAS  Google Scholar 

  43. Montag T, D’Ablaing G, Schlaerth J, Gaddis O, Morrow CP: Embryonal rhabdomyosarcoma of uterine corpus and cervix. Gynecologic Oncology 25: 171–194, 1986.

    Article  PubMed  CAS  Google Scholar 

  44. Shen JT, D’Ablaing G, Morrow CP: Alveolar soft part sarcoma of the vulva: Report of first case and review of literature. Gynecol Oncol 13: 120–128, 1982.

    Article  PubMed  CAS  Google Scholar 

  45. Audet - LaPointe P, Pacquin F, Guerard MJ, Carbonneau A, Methot F, Morand G: Case report: Leiomyosarcoma of the vulva. Gynecol Oncol 10: 350–355, 1980.

    Article  PubMed  CAS  Google Scholar 

  46. Hall DJ, Grimes MM, Goplerud DR: Epithelioid sarcoma of the vulva. Gynecol Oncol 9: 237–246, 1980.

    Article  PubMed  CAS  Google Scholar 

  47. DiSaia P, Rutledge F, Smith J: Sarcoma of the vulva. Obstet Gynecol 38: 180–184, 1971.

    PubMed  CAS  Google Scholar 

  48. Lloyd RV, Hajdu SI, Knapper WH: Embryonal rhabdomyosarcoma in adults. Cancer 51: 557–565, 1983.

    Article  PubMed  CAS  Google Scholar 

  49. Maurer HM, Moon T, Donaldson M, Fernandez C, Gehan EA, Hammond D, Hays DM, Lawrence W, Newton W, Ragab A, Raney B, Soule E, Sutow WW, Tefft M: The Intergroup Rhabdomyosarcoma Study: A preliminary report. Cancer 40: 2015–2026, 1977.

    Article  PubMed  CAS  Google Scholar 

  50. Hayes DM: Pelvic rhabdomyosarcomas in childhood: Diagnosis and concepts of management reviewed. Cancer 45: 1810–1814, 1980.

    Google Scholar 

  51. Ortner A, Weiser G, Haas H, Resch R, Dapunt O: Embryonal rhabdomyosarcoma (botryoid type) of the cervix: A case report and review. Gynecol Oncol 13: 115–119, 1982.

    Article  PubMed  CAS  Google Scholar 

  52. Barwick K, LiVolsi V: Malignant mixed mesodermal tumors of the ovary. Am J Surg Pathol 4: 37–42, 1980.

    Article  PubMed  CAS  Google Scholar 

  53. Anderson B, Turner D, Benda J: Ovarian sarcoma. Gynecologic Oncology 26: 183–192, 1987.

    Article  PubMed  CAS  Google Scholar 

  54. Hernandez W, DiSaia PJ, Morrow CP, Townsend DE: Mixed mesodermal sarcoma of the ovary. Obstet Gynecol 49: 59–63, 1977.

    PubMed  CAS  Google Scholar 

  55. Lele SB, Piver MS, Barlow JJ: Chemotherapy in management of mixed mesodermal tumors of the ovary. Gynecol Oncol 10: 298–302, 1980.

    Article  PubMed  CAS  Google Scholar 

  56. Morrow CP, D’Ablaing G, Bardy LW, Blessing JA, Hreshchyshyn MM: A clinical and pathologic study of 30 cases of malignant mixed Mullerian epithelial and mesenchymal ovarian tumors: A Gynecologic Oncology Group Study. Gynecologic Oncology 18: 278–292, 1984.

    Article  PubMed  CAS  Google Scholar 

  57. Morrow CP, Bundy BN, Hoffman J, Sutton G, Homesley H: Adriamycin chemotherapy for malignant mixed mesodermal tumor of the ovary. Am J Clin Oncol (CCT) 9 (1): 24–26, 1986.

    Article  CAS  Google Scholar 

  58. Moore M, Fine S, Sturgeon J: Malignant mixed mesodermal (MMM) tumors of the ovary: The Princess Margaret Hospital (PMH) Experience. abstr. 444, 1986.

    Google Scholar 

  59. Hanjani P, Petersen RO, Bonneil SA: Malignant mixed Mullerian tumor of the fallopian tube: Report of a case and review of literature. Gynecol Oncol 9: 381–393, 1980.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology and Oncology, The University of Alabama at Birmingham, Birmingham, AL, 35233, USA

    George A. Omura M.D.

  2. 223 Tumor Institute, University Hospital, Birmingham, AL, 35233, USA

    George A. Omura M.D.

Authors
  1. George A. Omura M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Orthopedic Surgery, Wayne State University School of Medicine, Detroit, Michigan, 48201, USA

    James R. Ryan MD (Associate Professor, Chief Orthopedic Oncology) (Associate Professor, Chief Orthopedic Oncology)

  2. Department of Internal Medicine, Division of Hematology-Oncology, Wayne State University School of Medicine, Detroit, Michigan, 48201, USA

    Laurence O. Baker D.O. (Professor, Director) (Professor, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Kluwer Academic Publishers

About this chapter

Cite this chapter

Omura, G.A. (1988). Treatment of Gynecologic Sarcomas. In: Ryan, J.R., Baker, L.O. (eds) Recent Concepts in Sarcoma Treatment. Developments in Oncology, vol 55. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2691-2_31

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-2691-2_31

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7714-9

  • Online ISBN: 978-94-009-2691-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation